[4-(1H-pyrazol-1-yl)phenyl]amine hydrochloride, 95.0%, 1g

N-(5-bromo-2-methoxybenzyl)cyclopentanamine hydrobromide, 95.0%, 1g

Benzyl (6-azaspiro[2.5]Octan-1-yl)carbamate hydrochloride, 98%, 100mg

GC capillary column ROTI®Cap-5 MS, 15 m, 0.25 mm, 0.25 µm, 1 Piece(s)

{5-[1-(benzylamino)cyclohexyl]-1H-tetrazol-1-yl}acetic acid, 95.0%, 10g

p-Tolyl trifluoromethanesulfonate, 95.0%, 5g

2-Propylvaleric Acid>99.0%(GC)(T)500mL

(R)-TERT-BUTYL (1,3-DIHYDROXY-3-METHYLBUTAN-2-YL)CARBAMATE, 95.0%, 5g

2-(1-(TERT-BUTOXYCARBONYL)-3-METHYLAZETIDIN-3-YL)ACETIC ACID, 95.0%, 250mg

3,6-Dibromo-2-chloropyridine, 95.0%, 1g

5,5',5''-(1,3,5-Triazine-2,4,6-triyl)tris(pyridin-2-amine), 95%, 1g

4-Amino-6,8-difluoro-2-methylquinoline, 97.0%, 250mg

3,4-Dichloro-2-methoxypyridine, 96%, 5g